Alan Ezekowitz, MBChB, D.Phil., FAAP is Co-Founder, President and CEO of Abide Therapeutics. We welcome Alan as the newest member of the QPID Health Advisory Board, announced in April. He is a pioneer in the field of innate immunity and previously served as senior vice president and franchise head of endocrine, bone, respiratory, and immunology at Merck Research Laboratories. He also served on the staff of Children’s Hospital of Boston, and later was chief of Pediatric Services and chaired the Executive Committee on Research at Massachusetts General Hospital.
Our Advisory Board is a group of nationally recognized experts in medicine, policy and healthcare IT who provide strategic guidance to our company. Over the past year, QPID Health has grown tremendously—rolling out new products and expanding both our customer and employee bases. Our Advisory Board members speak to the concerns of healthcare providers and guide us on corporate and product strategy as we continue to grow as a company.
Mike Doyle, our CEO, says of the Advisory Board, “We are honored to have attracted this group of esteemed healthcare scholars and leaders who share our passion for helping clinicians deliver the best possible care to patients while addressing issues of cost and efficiency.”
The members of the QPID Health Advisory Board are:
David W. Bates, MD, MSc, Chief of the Division of General Internal Medicine and Primary Care at Brigham and Women’s Hospital, Professor of Medicine at Harvard Medical School, and Professor of Health Policy and Management at the Harvard School of Public Health.
Alan Ezekowitz, MBChB, D.Phil., FAAP, Co-Founder, President and CEO of Abide Therapeutics
John D. Halamka, MD, MS, a Professor of Medicine at Harvard Medical School and Chief Information Officer of Beth Israel Deaconess Medical Center.
Julia Adler-Milstein, PhD, an Assistant Professor at University of Michigan whose research focuses on policy and management issues related to the use of IT in healthcare delivery.
John E. Osborn, JD, MIPP, a senior advisor with the international law firm Hogan Lovells, executive in residence with the healthcare group of Warburg Pincus, a regular contributor to Forbes.com and a faculty member at the University of Washington, Seattle.
Robert M. Wachter, MD, a Professor of Medicine at the University of California, San Francisco (UCSF), Associate Chairman of UCSF’s Department of Medicine, and Chief of UCSF’s 60-faculty Division of Hospital Medicine.